{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:09:37Z","timestamp":1754154577782,"version":"3.41.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL085561","R01-HL097047"],"award-info":[{"award-number":["R01-HL085561","R01-HL097047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.amjmed.2024.10.015","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:42:51Z","timestamp":1729129371000},"page":"495-503.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure"],"prefix":"10.1016","volume":"138","author":[{"given":"Phillip H.","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amiya A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Faselis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Deedwania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kanonidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauravpal S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherinne","family":"Arundel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Allman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2024.10.015_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0002","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0003","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0004","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11897-022-00559-w","article-title":"Polypharmacy in older heart failure patients: a multidisciplinary approach","volume":"19","author":"Sukumar","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0006","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.15420\/cfr.2022.14","article-title":"Polypharmacy in older people with heart failure: roles of the geriatrician and pharmacist","volume":"8","author":"Stefil","year":"2022","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"Khezrian","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0008","doi-asserted-by":"crossref","first-page":"18964","DOI":"10.1038\/s41598-020-75888-8","article-title":"Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41256-023-00311-4","article-title":"Prevalence and trends of polypharmacy in U.S. adults, 1999-2018","volume":"8","author":"Wang","year":"2023","journal-title":"Glob Health Res Policy"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/clc.22889","article-title":"Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving beta-blockers","volume":"41","author":"Lam","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0013","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.amjmed.2019.05.012","article-title":"Digoxin use and outcomes in patients with heart failure with reduced ejection fraction","volume":"132","author":"Qamer","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0014","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0735-1097(93)90403-N","article-title":"Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group","volume":"22","author":"Uretsky","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study","volume":"329","author":"Packer","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2019.05.064","article-title":"Digoxin discontinuation and outcomes in patients with heart failure with reduced ejection fraction","volume":"74","author":"Malik","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","article-title":"Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design","volume":"148","author":"Fonarow","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0018","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijcard.2011.10.089","article-title":"Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data","volume":"166","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"D. The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0021","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/pds.968","article-title":"On principles for modeling propensity scores in medical research","volume":"13","author":"Rubin","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0022","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCOUTCOMES.108.790634","article-title":"Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review","volume":"1","author":"Austin","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0023","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1177\/0962280215601134","article-title":"Estimating the effect of treatment on binary outcomes using full matching on the propensity score","volume":"26","author":"Austin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0024","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/j.amjmed.2020.08.030","article-title":"Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension","volume":"134","author":"Faselis","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/art.41803","article-title":"Cardiovascular safety of hydroxychloroquine in US veterans with rheumatoid arthritis","volume":"73","author":"Faselis","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0026","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjmed.2019.06.040","article-title":"Prior heart failure hospitalization and outcomes in patients with heart failure with preserved and reduced ejection fraction","volume":"133","author":"Malik","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0027","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.jacc.2019.04.022","article-title":"Systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction","volume":"73","author":"Arundel","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.archger.2008.06.009","article-title":"A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults","volume":"49","author":"Wahle","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0029","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0030","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehp222","article-title":"A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study","volume":"30","author":"Ahmed","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4757-3692-2_4","article-title":"Sensitivity to hidden bias","author":"Rosenbaum","year":"2002","journal-title":"Observational Studies"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0032","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2005.02.091","article-title":"Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis","volume":"46","author":"Adams","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0033","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0034","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0035","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0036","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2008.03.048","article-title":"Coordinators. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program","volume":"52","author":"Fonarow","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0037","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050329","article-title":"Methods for estimating the occurrence of polypharmacy by means of a prescription database","volume":"53","author":"Bjerrum","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2024.10.015_bib0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324006387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324006387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:49:13Z","timestamp":1753361353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934324006387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0002934324006387"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.10.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}